|
|
 | |  | | | AFFARI1 | 08:45 - 10:15
PLENARY SESSION - CLIMACTERIC MEDICINE |  | |  | | Lello Stefano
Pharmacology of post-menopause and aging |
| |  | |  |
| | | | Brincat Mark
The ageing of connective tissues in women: the menopause crossing |  |
| | | | |
| |
10:35 - 11:05
PLENARY LECTURE | | | | | Lobo Rogerio
Why is estrogen protective against cardiovascular disease, but not against stroke ? |
| | | | |
| |
11:10 - 13:10
PLENARY SESSION - HORMONAL CONTRACEPTION FOR WOMAN AND MAN'S HEALTH | | | | | Fruzzetti Franca
Future perspectives for hormonal contraception and woman's health |
| | | | |
| | | | Blithe Diana
Current status of male contraceptive development |
| | | | |
| | | | Maia Hugo
Hormonal contraception and the risk of cancer | |
| | | | |
| | | | Skouby Sven
Metabolic actions of hormonal contraceptives | |
| | | | |
| |
14:10 - 16:10
PLENARY SESSION - HORMONAL REGULATION OF CARDIOVASCULAR FUNCTION | | | | | Karas Richard
Molecular mechanisms regulating rapid vascular dilation by estrogen receptors | |
| | | | |
| | | | Vaughan Douglas
Hormonal regulation of the renin-angiotensin-aldosterone system and endothelial function in postmenopausal women | |
| | | | |
| | | | Rosano Giuseppe
Metabolic therapy for the treatment of cardiovascular diseases in the Perimenopausal Woman |
| | | | |
| | | | Lobo Rogerio
The future of clinical cardiovascular trials of HRT in menopausal medicine |
| | | | |
| |
16:30 - 18:30
PLENARY SESSION - OBESITY AND GYNECOLOGICAL ENDOCRINOLOGY | | | | | Berg Gabriela
Abdominal adiposity, sex hormones and insulin resistance | |
| | | | |
| | | | Milewicz Andrzej
Polymorphisms of endocannabinoid receptors and serum adiponectin and obese phenotype in postmenopausal women | |
| | | | |
| | | | Stevenson John
Should all menopausal women with metabolic syndrome receive HRT? | |
| | | | |
| |
|
| |  | |  |
| | | | | AFFARI2 | 08:45 - 10:15
PLENARY SESSION - PATHOGENESIS OF PREECLAMPSIA: FROM IMMUNOLOGY TO ANGIOGENESIS INHIBITION | | | | | Lyall Fiona
Mechanisms underlying failed trophoblast invasion in preeclampsia |
| | | | |
| |
10:35 - 11:05
PLENARY LECTURE | | | | | Da ya Salim
Dydrogesterone - the missing link to improved maternal blood flow |
| | | | |
| |
11:10 - 13:10
PLENARY SESSION - CURRENT ISSUES IN PRETERM BIRTH AND PLACENTAL FUNCTION REGULATION | | | | | Petraglia.F
Preterm birth and stress hormones |
| | | | |
| | | | Iwashita Mitsutoshi
Regulation of placental function by insulin-like growth factor (IGF) and IGF-binding proteins | |
| | | | |
| |
14:10 - 16:10
PLENARY SESSION - UTERINE FIBROIDS: FROM THE BENCH TO THE BEDSIDE | | | | | Chegini Nasser
MicroRNAs and fibroids |
| | | | |
| | | | Maruo Takeshi
Nonsurgical treatments of fibroids: Selective progesterone receptor modulators | |
| | | | |
| |
16:30 - 18:30
PLENARY SESSION -M NEW HORIZONS IN ENDOMETRIOSIS | | | | | Zondervan Krina
Genetics of endometriosis |
| | | | |
| | | | Osuga Yutaka
Immune and inflammatory aspects of endometriosis | |
| | | | |
| |
|
| | | | |
| | | | | AFFARI3 | 08:45 - 10:15
PLENARY SESSION -TARGETING THE ENDOMETRIUM WITH NEW MOLECULES: SPRMS AND SARMS | | | | | Bouchard Philippe
The SPRMS and SARMS |
| | | | |
| | | | Marbaix Etienne
Molecular mechanisms of SPRMS on endometrial gene expression | |
| | | | |
| |
10:35 - 11:05
PLENARY LECTURE | | | | | Lunenfeld Bruno
Diagnosis and management of pcos from birth to senescence |
| | | | |
| |
11:10 - 13:10
PLENARY SESSION - POLYCYSTIC OVARY SYNDROME | | | | | Hart Roger
Prenatal influences on female reproduction |
| | | | |
| |
14:10 - 16:10
PLENARY SESSION ORGANIZED BY SOCIETÀ ITALIANA DI EMBRIOLOGIA RICERCA E RIPRODUZIONE - OOCYTE QUALITY IN BIOLOGY OF REPRODUCTION AND HUMAN IVF | | | | | Ledda Sergio
Cellular and biochemical criteria to assess oocyte quality | |
| | | | |
| | | | Chigioni Sara
Domestic animal models as a tool to understand human oocyte maturation | |
| | | | |
| | | | Paffoni Alessio
Parthenogenesis as a system to validate novel methodologies in human IVF | |
| | | | |
| |
16:30 - 18:30
PLENARY SESSION - WINNERS UNDER 34 COMPETITION SYMPOSIUM | | | | | Broer Simone L
Anti-Müllerian Hormone in the prediction of menopausal transition or menopause; a follow-up study |
| | | | |
| | | | Meehan K
Characterisation of early ovarian cancer biomarkers | |
| | | | |
| | | | Sundermann Erin
The Effects of Menstrual Cycle Phase & Stress on Cognitive Flexibility | |
| | | | |
| | | | Taran AF
Magnetic Resonance Elastography Allows Quantitative Assessment of Uterine Leiomyomas | |
| | | | |
| | | | Pelekanou V
ER17p, a peptide corresponding to the regulatory platform P295-T311 of ER-alpha: role in actin cytoskeleton, migration and apoptosis |
| | | | |
| |
|
| | | | |
| | | | | AFFARI4 | 08:45 - 10:15
ORAL PRESENTATIONS - PREMATURE OVARIAN INSUFFICIENCY | | | | | Ayed W
Clinical, Cytogenetic and Molecular Study in Premature Ovarian Failure. A Tunisian Study |
| | | | |
| | | | Dragojevic-Dikic S,
The influence of hormone replacement therapy(HRT) on fertility in premature ovarian failure(POF) patients | |
| | | | |
| | | | Janse F
Similar presentation of sporadic and familial premature ovarian failure (POF) | |
| | | | |
| | | | Lipovac M
AMH - an eligible marker of ovarian function for oncological patients undergoing ovarian tissue banking | |
| | | | |
| | | | Moridi I
Does ovarian drilling precede premature ovarian failure in Clomiphene resistant PCOD patients? |
| | | | |
| | | | Mason H.
Premature ovarian insufficiency (POI) | |
| | | | |
| | | | Russo L.
Premature ovarian insufficiency |
| | | | |
| | | | Di Gangi E
Bone mass in Primary Ovarian Insufficiency | |
| | | | |
| | | | Takagi K
Successful pregnancy after intermittent hormone replacement therapy in a patient with premature ovarian failure | |
| | | | |
| | | | Vujovic S
Characteristics of women with "idiopathic" premature ovarian failure |
| | | | |
| |
11:10 - 13:10
ORAL PRESENTATIONS - REPRODUCTIVE NEUROENDOCRINOLOGY | | | | | Athanasopoulos N
Differences in characteristics of dysfunctional uterine bleeding in patients with immaturity of the hypothalamic-pituitary-ovarian (HPO) axis and polycystic ovarian syndrome | |
| | | | |
| | | | Bonin C
Role of body weight and training profile in menstrual dysfunction of professional and non-professional classical ballet dancers | |
| | | | |
| | | | Czyzyk A
Brain-derived neurotrophic factor levels in patients with Turner syndrome | |
| | | | |
| | | | Gambera A
Correlation between endocrine profile, heart rate variability and neuropsychiatric parameters in adolescents with anorexia nervosa and functional hypotalamic amenorrhea | |
| | | | |
| | | | Rassi Mahamed
Ovarian gene expression after melatonin supplementation on the adult female rats | |
| | | | |
| | | | Malejczyk J
Changes of natural killer cell cytotoxic activity and immunoregulatory cytokine production during menstrual cycle | |
| | | | |
| | | | Gaspari L.
No association between the TTTA repeats polymorphism of aromatase (CYP19) gene and the precocious puberty development | |
| | | | |
| | | | Podfigurna-Stopa A
Serum kisspeptin concentrations in patients with functional hypothalamic amenorrhea | |
| | | | |
| | | | Spinelli C
Ovarian lesions in children and adolescents: evaluation and management of 104 cases |
| | | | |
| | | | Matarazzo P.
Persistency of autonomous ovarian hyperfunction during adolescence and early adult age in female with McCune-Albright syndrome | |
| | | | |
| | | | Tsampalas M
The endometrial hCG/LH receptor: quantification throughout the menstrual cycle |
| | | | |
| | | | Zektser V
Pathogenetic aspects of hypogonadotropic hypogonadism in women of reproductive age |
| | | | |
| |
14:10 - 16:10
ORAL PRESENTATIONS - ANDROGENS AND HYPERANDROGENISMS | | | | | Benelli E
Dyslipidemia and polycistic ovary syndrome | |
| | | | |
| | | | Silva Ismael
Genetic analysis and cAMP measurement between lean and obese (ob/ob) anovulating mice | |
| | | | |
| | | | Boldrini França Fernandes J
Hormonal oral contraceptive alone or associated with metformin on cardiovascular risk markers in polycystic ovary syndrome women | |
| | | | |
| | | | Bonin C
Insulin resistance is associated with hyperandogenism and oligo-anovulation, but not with the ultrasonographic features of the ovaries, in the woman with polycistic ovary syndrome (PCOS) | |
| | | | |
| | | | Khaki A
Effect of Androgenic Activity of Zingiber officinale on Serum FSH, LH, Testosterone hormone and Spermatogenesis in Rat |
| | | | |
| | | | Link K
Circadian and menstrual cycle variation of serum androstenedione |
| | | | |
| | | | Naessén S
So similar and so different: Androgen status in bulimic women | |
| | | | |
| | | | Papadimitriou D
Serum androgens are increased in the presence of MTHFR ala222val polymorphism in healthy postmenopausal women | |
| | | | |
| | | | Peruzzi E
Flutamide hepatotoxicity: our experience over 176 patients | |
| | | | |
| | | | Rousset-Jablonski C
Menstrual Cycle Disorders and Hormonal Alterations in Women with Vascular Liver Disease | |
| | | | |
| | | | Stomati M
Low-dose oral deydroepiandrosterone (DHEA) supplementation in postmenopausal women | |
| | | | |
| |
16:30 - 18:30
ORAL PRESENTATIONS - BREAST CANCER | | | | | Pelekanou V
hERa36, a new variant of ERa: Expression and potential biological relevance in breast cancer |
| | | | |
| | | | Baumgärtner AK
Breast cancer outcome in peri- versus postmenopausal women with or without hormone therapy prior to diagnosis | |
| | | | |
| | | | Britton K
Could SP cells be an indicator of progression to hormone non-responsive breast cancer? | |
| | | | |
| | | | Capittini C
Birthweight and cord blood haematopoietic stem cell content: is there a connection for cancer risk in adulthood? | |
| | | | |
| | | | Goglia L
Progesterone enhances breast cancer cell mobility by the nongenomic activation of focal adhesion kinase |
| | | | |
| | | | Kampa M
Membrane acting androgens specifically modify early gene transcription in breast cancer cells | |
| | | | |
| | | | Mozdarani S
Repair kinetics of radiation induced DNA damages in leukocytes of breast cancer patients as a measure of breast cancer susceptibility |
| | | | |
| | | | Pfeiler G
Influence of the dramatic fall of HRT prescription on postmenopausal breast cancer incidence: the Austrian Data |
| | | | |
| | | | Tosi V
Effect of dydrogesterone, dehydro-dydrogesterone, progesterone and medroxyprogesterone acetate on T47D breast cancer cell migration and invasion | |
| | | | |
| |
|
| | | | |
| | | | | AUDITORIUM | 08:45 - 10:15
PLENARY SESSION - NEW FRONTIERS IN ART | | | | | Devoto Luigi
The physiological function of progesterone receptor in the human ovulatory process |
| | | | |
| | | | Monteleone Patrizia
Role of thyroid autoimmunity in female infertility |
| | | | |
| | | | Fujii Haruko
Blastocyst attachment is regulated by Eph-ephrin A system |
| | | | |
| | | | Tarlatzis Basil
Chances for fertility preservation and ovulation induction in POF patients |
| | | | |
| |
10:35 - 11:05
PLENARY LECTURE | | |
11:10 - 13:10
SPONSORED SYMPOSIUM - IBSA - FOSTIMON, HUMAN TYPE FSH: FROM BASIC SCIENCE TO CLINICAL PRACTICE | | | | | Filicori Marco
FSH isoforms in human reproduction: an overview |
| | | | |
| | | | Gürgan Timur
Highly glycosylated FSH: available clinical results and investigational issues | |
| | | | |
| | | | Ménézo Yves
Effects of FSH stimulation regimens on the pattern of mRNA expression in human cumulus cells |
| | | | |
| | | | Aboulghar Mohamed
Efficacy and safety of FSH drug products for ART in PCOS |
| | | | |
| |
14:10 - 16:10
SPONSORED SYMPOSIUM - THERAMEX MERCK SERONO - ORAL CONTRACEPTION: THE ACHIEVEMENT OF 50 YEARS OF HORMONAL RESEARCH | | | | | Genazzani Andrea R.
Programma del Simposio |
| | | | |
| | | | Sitruk Ware Regine
Hormonal creativity in contraception |
| | | | |
| | | | Bruni Vincenzina
How nomegestrol acetate leads to estradiol in a monophasic regimen? |
| | | | |
| | | | Jamin Christian
Metabolic consequences from such evolution |
| | | | |
| | | | Fruzzetti Franca
Achieving lower impact on hemostasis parameters |
| | | | |
| |
16:30 - 18:30
SPONSORED SYMPOSIUM - SCHERING PLOUGH - LOW ? DOSE CONTRACEPTION: WHY, HOW AND HOW MUCH | | | | | Nappi Rossella
Counseling in contraception: fundamental to a tailored approach - The tolerability of intravaginal administration of hormonal contraception | |
| | | | |
| | | | Cagnacci Angelo
The benefits of intravaginal administration of hormonal contraception |
| | | | |
| | | | Benedetto Chiara
To "E" or not to "E": contraception without estrogen |
| | | | |
| |
18:30 - 19:30
OPENING CEREMONY | | | | | Genazzani Andrea R.
President of the 14th World Congress of Gynecological Endocrinology |
| | | | |
| | | | Mendelsohn Michael
OPENING LECTURE: The biology of estrogen receptor action in cardiovascular health and disease | |
| | | | |
| |
|
| | | | |
| | | | | ONICE | 08:45 - 10:15
ORAL PRESENTATIONS - FEMALE SEXUAL FUNCTION AND DYSFUNCTION | | | | | Balasko B
Psycho emotional impact of women with provoked vestibulodynia |
| | | | |
| | | | Wallwiener LM
The Sexual Life of German Medical Students: Investigation of the prevalence of sexual dysfunction and the impact of contraception |
| | | | |
| | | | Chedraui P
Assessment of sexuality after hysterectomy using the Female Sexual Function Index |
| | | | |
| | | | Firquet A
Androgen deficiency during combined oral contraceptives |
| | | | |
| | | | Loto O
Pattern and Correlates of Premenstrual Symptoms (PMS) amongst Nigerian University Students |
| | | | |
| | | | Melis I
Sexual function is impaired in patients with endometriosis |
| | | | |
| | | | Mezones-Holguín E
Female sexual dysfunction in young people at a public university in northern Peru |
| | | | |
| | | | Moghasemi S
Female sexual dysfunction in Iranian postmenopausal women |
| | | | |
| |
11:10 - 13:10
ORAL PRESENTATIONS - MEDICALLY-ASSISTED PROCREATION | | | | | Crha I
Luteal-phase GnRH agonist administration in IVF/ICSI cycles stimulated with the long GnRH agonist protocol |
| | | | |
| | | | Devesa M
Impact of increased body mass index on IVF outcomes | |
| | | | |
| | | | Gomes CM
Administration of recombinant (r)hCG on the first day of the menses produces age independent rescue of the corpus luteum |
| | | | |
| | | | Guglielmino MR
Apoptotic Machinery in aging: gene expression profiles in oocytes and in cumulus cells by High Throughput Real Time PCR |
| | | | |
| | | | Inaudi P
Low-dose rFSH administration is effective and safe in PCOS women in IUI or IVF cycles |
| | | | |
| | | | Jeve Yadava B
The combined use of Anti-Mullerian Hormone and age to predict the ovarian response to controlled ovarian hyper stimulation in poor responders |
| | | | |
| | | | Thong KJ
Evaluation of Anti-Mullerian hormone in predicting cumulative pregnancy outcome during assisted reproduction | |
| | | | |
| | | | Koloda YA
Effect of overweight and obesity on assisted reproductive technology outcomes |
| | | | |
| | | | Niu ZH
Effects of exogenous luteinizing hormone on patients with relative LH deficiency after pituitary down-regulation during controlled ovarian hyperstimulation |
| | | | |
| | | | Santonocito M
Identification and validation of molecular markers of human oocyte biological quality after vitrification |
| | | | |
| | | | Venetis CA
Addition of rLH in patients undergoing ovarian stimulation with rFSH and GnRH analogues for IVF: a meta-analysis | |
| | | | |
| | | | Pelekanou V
ER17p, a peptide corresponding to the regulatory platform P295-T311 of ER-alpha: role in actin cytoskeleton, migration and apoptosis |
| | | | |
| |
14:10 - 16:10
ORAL PRESENTATIONS - INFERTILITY | | | | | Dinopoulou V
Oct-4 expression in fetal cells recovered from the lower uterine pole |
| | | | |
| | | | Dziadecki W
The role of human neutrophil peptides 1-4 in pathogenesis of male genital tract inflammation |
| | | | |
| | | | Garzia E
Prolactin and pro-inflammatory cytokines expression at the feto-maternal interface in the first trimester implantation failure |
| | | | |
| | | | González Pérez I
Duration of fertility age and multigenic combination of estrogen related genes: a propotional hazard model |
| | | | |
| | | | Grande G
Conception and altered semen parameters: retrospective analysis of 453 pregnancies |
| | | | |
| | | | Kabir SN
The size of ovarian follicular reserve impacts the expression of GDF-9 and NOBOX, and modulates the rate of follicular atresia |
| | | | |
| | | | Kaur S
Receptor mediated agglutination of human spermatozoa by spermagglutinating factor isolated from Staphylococcus aureus | |
| | | | |
| | | | Maragno L
Endometrial function during ART |
| | | | |
| | | | Papini F
Fragmin administration in women undergoing program of assisted fertilization |
| | | | |
| | | | Shamsi MB
ROS levels and DNA damage - association with poor sperm quality and Medically Assisted Procreation failure |
| | | | |
| | | | Viana G
Endometritis: hysteroscopic follow-up after antibiotic therapy in infertile patients |
| | | | |
| |
16:30 - 18:30
ORAL PRESENTATIONS - REGULATION OF THE ENDOMETRIUM | | | | | Asaturova AV
The efficacy of PTEN expression assessment in endometrial hyperplasia and other possible markers for endometrial precancerous process identification and prediction |
| | | | |
| | | | Botto de Barros Filho AM
Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women |
| | | | |
| | | | Spratte J
Heparin and low molecular weight heparins modulate the decidualization of human endometrial stromal cells | |
| | | | |
| | | | Fujiwara H
EphrinA1 induces cell attachment and intercellular dissociation in Ishikawa cells |
| | | | |
| | | | Gentilini D
The endocannabinoid system controls endometrial plasticity |
| | | | |
| | | | González-Ramos R
Nuclear factor-kappaB p65 and RelB peptides expression in human endometrium across the menstrual cycle |
| | | | |
| | | | Hulchiy M
Thyroid stimulating hormone receptor and thyroid hormone receptor alpha expression in the uterus of cynomolgus macaques: effects of steroid hormone treatment |
| | | | |
| | | | Kovalenko Y
Role of nonspecific proteolytic enzymes and their inhibitors in endometrial hyperplasia development |
| | | | |
| | | | Malenkovic G
Endometrial pathologies associated with Tamoxifen in breast cancer patients with postmenopausal vaginal bleeding |
| | | | |
| | | | Schaefer WR
Effects of drugs and endocrine active chemicals on endometrial gene-expression biomarkers in vitro |
| | | | |
| | | | Singh M
Endometrial Tuberculosis- Case for Differential Diagnosis in Abnormal Uterine Bleeding In Late Reproductive Period | |
| | | | |
| | | | Tan O
Activation and action of ezrin protein during the endometrial cycle and its potential role in embryo implantation |
| | | | |
| |
|
| | | | |
| | | | | VERDE | 08:45 - 10:15
PLENARY SESSION - STEM CELLS | | | | | Enseñat Roberto
Reprogramming as a new approach to obtain patient specific stem cells |
| | | | |
| | | | Zhou Canquan
The establishment of human parthenogenetic stem cell line and its DNA methylation | |
| | | | |
| |
10:35 - 11:05
PLENARY LECTURE | | |
11:10 - 13:10
NEW CONCEPTS ON GONADOTROPHIN SIGNALING | | | | | Zygmunt Marek
Vascular actions of gonadotrophins |
| | | | |
| | | | Zaidi Mone
Actions of gonadotrophins on the bone |
| | | | |
| |
14:10 - 16:10
PLENARY SESSION - PREMATURE OVARIAN FAILURE | | | | | Fauser Bart
Anti-Mullerian Hormone and other markers of residual ovarian potential | |
| | | | |
| |
16:30 - 18:30
PLENARY SESSION - OVARIAN CANCER | | | | | Pecorelli Sergio
Hormones and ovarian cancer |
| | | | |
| | | | Prat Jaime
Subclassification of ovarian cancer based on pathology and genetics |
| | | | |
| | | | Metka Markus
Antioxidative, anti-inflammatory and chemopreventive potency of phytosubstances: the isoflavone resveratrol and epigallocatechin |
| | | | |
| |
|
| | | | |
| | | | | AFFARI1 | 08:30 - 10:00
ACADEMY OF HUMAN REPRODUCTION - THE FUTURE TRENDS OF INDUCTION OF OVULATION DEDICATED TO THE LATE DR. SHELDON SEGAL | | | | | Naftolin Frederick
The Exquisite Choreography of Follicle Development and ovulation by the Hypothalamus, Pituitary and Ovary | |
| | | | |
| | | | Frydman Réné
Can we identifie the so call good oocyte after ovarian stimulation for ART |
| | | | |
| | | | Shoham Zeev
Luteal support in ART cycles: Why, with what, and for how long? | |
| | | | |
| |
10:30 - 11:00
PLENARY LECTURE | | | | | Uzan Serge
Fertility preservation in woman with breast cancer : a need for a global strategy |
| | | | |
| |
11:10 - 13:10
PLENARY SESSION - BREAST CANCER | | | | | Mueck Alfred
Role of estrogen metabolites in breast cancer |
| | | | |
| | | | von Schoultz Bo
Mammographic density to monitor the breast during hormone therapy | |
| | | | |
| |
14:10 - 15:00
DEBATE - DIAGNOSTIC TOOLS FOR MENOPAUSAL SYMPTOMS | | |
15:00 - 17:00
SPONSORED SYMPOSIUM - BAYER SCHERING PHARMA - YOUNG AT HEART | | | | | Rosano Giuseppe
Cardiovascular Aspects of Drospirenone |
| | | | |
| | | | Collins Peter
Managing a Woman's Cardiovascular Risk: a Gynecologists' Guide |
| | | | |
| |
17:20 - 19:20
PLENARY SESSION - FROM NATURE FOR MENOPAUSE | | | | | Jungbauer Alois
Bioactive compounds recommended for nutrition of climacteric women | |
| | | | |
| | | | Cianci Antonio
Isoflavones and lactobacilli for a natural approach to menopausal disorders | |
| | | | |
| | | | Nachtigall Lila E
Clotting Issues in Oral Estrogen, Transdermal Estrogen and Femarelle | |
| | | | |
| |
19:20 - 20:00
ISGE GENERAL ASSEMBLY | | |
|
| | | | |
| | | | | AFFARI2 | 08:30 - 10:00
SYMPOSIUM ORGANIZED BY SOCIEDAD ARGENTINA DE ENDOCRINOLOGIA GINECOLOGICA Y REPRODUCTIVA - OVARIAN AGEING: IMPACT FOR FERTILITY PRESERVATION | | | | | Cortelezzi Marta
Marcadores endocrinos de reserva ovarica (Endocrine markers for ovarian reserve) | |
| | | | |
| | | | Nolting Manuel
FOP: consecuencias reproductivas y no reproductivas (POF: reproductive and non reproductive consequences) | |
| | | | |
| | | | Lombardi E
Preservación de la fertilidad (Fertility preservation) | |
| | | | |
| | | | Moses Nora
Implicancias endocrino-metabolicas en mujeres mayores de 40 (Endocrine and metabolic implications of ovarian aging) | |
| | | | |
| |
10:30 - 11:00
PLENARY LECTURE | | |
11:10 - 13:10
PLENARY SESSION - CHRONIC ANOVULATION | | | | | Lanzone Antonio
Diagnosis and clinical management of menstrual irregularities and infertility | |
| | | | |
| | | | Di Carlo C
Long-term health consequences of chronic anovulation | |
| | | | |
| |
14:10 - 15:00
SPONSORED SYMPOSIUM - HRA PHARMA - A NEW LOOK AT EMERGENCY CONTRACEPTION | | | | | Moreau Caroline
Emergency contraception: A real need for a second chance - Epidemiological evidence | |
| | | | |
| | | | Glasier Anna
ellaOne® Ulipristal Acetate: Improved efficacy - Clinical evidence | |
| | | | |
| |
15:00 - 17:00
PLENARY SESSION -ECM ENDOMETRIOSIS: FROM THE BENCH TO THE BEDSIDE | | | | | Kiesel Ludwig
Stem cells in endometrium and endometriosis |
| | | | |
| | | | Angioni Stefano
Pain in endometriosis: central sensitization or peripheral mechanisms? |
| | | | |
| | | | Schindler Adolf
Dienogest ? a novel progestogen for the treatment of endometriosis |
| | | | |
| |
17:20 - 19:20
PLENARY SESSION - ENDOMETRIAL HYPERPLASIA AND CANCER | | | | | Prat Jaime
From endometrial hyperplasia to endometrial cancer | |
| | | | |
| | | | Baird David
Hormone treatment for the prevention and treatment of endometrial hyperplasia with preservation of fertility | |
| | | | |
| | | | Hourvitz Ariel
In vitro fertilization after endometrial adenocarcinoma | |
| | | | |
| |
|
| | | | |
| | | | | AFFARI3 | 08:30 - 10:30
EDUCATIONAL COURSE - BAYER ITALIA - CONFRONTI CLINICI IN CONTRACCEZIONE ORMONALE - PRIMA SESSIONE | | | | | Lello Stefano
Estroprogestinici e iperandrogenismo |
| | | | |
| |
11:00 - 13:00
EDUCATIONAL COURSE - BAYER ITALIA - CONFRONTI CLINICI IN CONTRACCEZIONE ORMONALE - SECONDA SESSIONE | | | | | Fruzzetti Franca
Personalizzazione della terapia contraccettiva |
| | | | |
| |
14:10 - 15:00
DEBATE - PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS : HORMONES OR BISPHOSPHONATES ? | | |
15:00 - 19:20
EDUCATIONAL COURSE - WYETH/PFIZER - CONTROVERSIE CLINICO-TERAPEUTICHE NELL'AMBULATORIO DEL GINECOLOGO | | | | | Genazzani Andrea R.
Il cervello femminile e le sue vulnerabilità nell'ambulatorio del ginecologo | |
| | | | |
| | | | Nappi Rossella
Le problematiche sessuali e la pratica clinica: come riconoscerle e affrontarle | |
| | | | |
| | | | Maffei Silvia
Cuore vasi e terapia ormonale: l'importanza di un inizio precoce |
| | | | |
| | | | Lello Stefano
Perché l'osteoporosi post-menopausale è di gestione del ginecologo? |
| | | | |
| | | | Perino Antonio
Infezioni vaginali e flogosi pelvica: un binomio non ancora risolto | |
| | | | |
| |
|
| | | | |
| | | | | AFFARI4 | 08:30 - 10:00
SYMPOSIUM ORGANIZED BY POLISH GROUP OF GYNECOLOGICAL ENDOCRINOLOGY - HOT TOPICS IN GYNECOLOGICAL ENDOCRINOLOGY | | | | | Smolarczyk Roman
Practical solution of hyperprolactinaemia in gynecological practice | |
| | | | |
| |
11:10 - 13:10
ORAL PRESENTATIONS - HORMONES AND HORMONE RECEPTORS | | | | | Black SM
Development of a peptide that attenuates the plasma membrane translocation of estrogen receptor alpha | |
| | | | |
| | | | Cork DMW
Alternatively Spliced Progesterone Receptor (PR) Expression in Breast Cancer | |
| | | | |
| | | | Giannini A
Progesterone counteracts estrogen-induced increases in central and peripheral Brain- Derived Neurotrophic Factor in female ovx rats | |
| | | | |
| | | | Kechagioglou K
Association of human progesterone receptor polymorphisms with the probability of pregnancy: a systematic review | |
| | | | |
| | | | Leitao BB
Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals | |
| | | | |
| | | | Lucas C
The expression of the transcription factor WT1 (Wilms tumour suppressor gene) within the human uterus during decidualization | |
| | | | |
| | | | Medjakovic S
Potent AhR agonist from sauerkraut modulates the ER pathway |
| | | | |
| | | | Zullino.S
Rapid signaling of estrogen to focal adhesion kinase in endothelial cells |
| | | | |
| | | | Tyson-Capper A
The role of endogenous ligands in modulating inflammation and TLR signalling events associated with preterm birth | |
| | | | |
| | | | Tyson-Capper A
Non-classical pathways are responsible for the immunomodulatory and anti-inflammatory action of progesterone in human myometrial and amnion cells | |
| | | | |
| | | | Vladic-Stjernholm Y
Prostaglandin treatment is followed by a withdrawal of progesterone and androgen in the human uterine cervix | |
| | | | |
| | | | Wilhelm F
Estradiol activates Akt/protein kinase B in postmenopausal endometrium | |
| | | | |
| |
15:00 - 17:00
ORAL PRESENTATIONS - GYNECOLOGICAL CANCERS | | | | | Bellati F
Improvement of QoL after hormone replacemet therapy in cervical cancer survivors |
| | | | |
| | | | Benedetti Panici P
Improvement of quality of life and immunological fitness targeting VEGF in platinum refractory ovarian cancer patient |
| | | | |
| | | | Cole LA
Hyperglycosylated hCG in tumor invasion |
| | | | |
| | | | Franchi V
Nutritional status in oncological gynaecology. Which importance? |
| | | | |
| | | | Jadoon B
Analysis of outcome in women with borderline glandular change |
| | | | |
| | | | Karimi Zarchi M
Fertility sparing in infertile women with endometrial cancer or complex atypical hyperplasia |
| | | | |
| | | | Koutlaki N
Relation of body mass index and blood androgens levels to tumor prognostic factors among premenopausal women with breast cancer |
| | | | |
| | | | Laurelli G
Conservative treatment of early endometrial cancer: preliminary results of a pilot study | |
| | | | |
| | | | Puett D
Gene expression profiling of ovarian cancer cells post-activation of the LH receptor | |
| | | | |
| | | | Wincewicz Andrzej
Eventual proapoptotic or anti-apoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ER-alpha overexpression in endometrioid adenocarcinoma | |
| | | | |
| | | | Wincewicz A
STAT3, E-cadherin and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile | |
| | | | |
| | | | Zafran N
Plexin B1 is differentially expressed in biopsies from normal and tumoral endometrium having tissue specific effect on in-vitro invasion | |
| | | | |
| |
17:20 - 19:20
ORAL PRESENTATIONS - MISCARRIAGE AND ABORTION | | | | | Coccia ME
Recurrent Pregnancy Loss: the effectiveness of a new therapeutic approach |
| | | | |
| | | | El Kamel-Lebbi I
Male chromosomal implication in recurrent spontaneous abortions | |
| | | | |
| | | | Essadi FM
Efficacy of Low dose Aspirin & Low-molecular-weight- heparin treatment in women with recurrent first trimester pregnancy loss |
| | | | |
| | | | Hedayat Z
Higher frequency of anti-thyroid antibodies in patients with recurrent spontaneous abortion may stem from impaired vitamin D3 metabolism | |
| | | | |
| | | | Horie A
Laeverin, a novel membrane-bound aminopeptidase, regulates early human placentation |
| | | | |
| | | | Russu M
Pregnancy outcome after preconceptional and during window of implantation Vaginal Micronized Progesterone administration in recurrent pregnancy loss |
| | | | |
| | | | Salvador S
Short-term follow-up of voluntary abortion in an Italian centre: a prospective analysis of 186 cases | |
| | | | |
| | | | Drews Krysztof
The Arg353Gln polymorphism of factor VII in women with recurrent miscarriages |
| | | | |
| | | | Spitaleri M
Antithyroid antibodies and Recurrent Pregnancy Loss | |
| | | | |
| | | | Toulis Konstantinos
Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing in-vitro fertilization: a systematic review and a meta-analysis | |
| | | | |
| | | | Turp AB
Are We Missing Out Evaluation of Paternal Chromosomal Abnormality In Recurrent Miscarriage? Varicocele and Sperm FISH | |
| | | | |
| | | | Tutchenko TN
Glutathione S-transferase M1 and T1 Polymorphisms and the Risk of Recurrent Early Pregnancy Loss in Women with High Perceived Stress | |
| | | | |
| |
|
| | | | |
| | | | | AUDITORIUM | 08:30 - 10:00
SYMPOSIUM ORGANIZED BY ASSOCIATION FRAN?AISE POUR L'?TUDE DE LA MENOPAUSE - WHEN MENOPAUSE COMES TOO EARLY | | | | | Scemama Lydia Marie
Premature ovarian failure and gynecology |
| | | | |
| | | | Lachowsky Michèle
Premature menopause and patients |
| | | | |
| |
10:30 - 11:00
PLENARY LECTURE | | |
11:10 - 13:10
SPONSORED SYMPOSIUM - THERAMEX MERCK SERONO - A WOMAN'S JOURNEY: 3 MAIN PERIODS OF A WOMAN'S LIFE THROUGH 3 THERAPEUTIC AREAS | | | | | Collins Peter
Cardiovascular issue |
| | | | |
| |
14:10 - 15:00
DEBATE - SHOULD THERE BE AN INTERNATIONAL LIMIT ON THE NUMBER OF FERTILIZED OOCYTES THAT ARE IMPLANTED IN A WOMAN AT ONE TIME ? | | |
15:00 - 17:00
SPONSORED SYMPOSIUM - MERCK SERONO - THE FUTURE OF FERTILITY: INDIVIDUALISED THERAPY | | | | | Revelli Alberto
Mild stimulation protocols: from super ovulation to natural IVF | |
| | | | |
| |
17:20 - 19:20
PLENARY SESSION - FOLLICULAR GROWTH, OOCYTE QUALITY, EMBRIO SELECTION AND ENDOMETRIAL RECEPTIVITY: AN UNSOLVED PUZZLE | | | | | Artini Paolo G
Human oocyte cryopreservation by Vitrification technique |
| | | | |
| | | | Picton Helen M
In vitro models for understanding follicular growth and maturation |
| | | | |
| |
|
| | | | |
| | | | | ONICE | 08:30 - 10:00
ORAL PRESENTATIONS - FERTILITY AND PREGNANCY IN 2010 | | | | | Carminati R
Vaginal Salpingectomy as Surgical Treatment for Extrauterine Tubal Pregnancy: a Pilot Randomized Study | |
| | | | |
| | | | Klimov V
Autosensibilization to the progesterone and syndrome loss of pregnancy |
| | | | |
| | | | Marin JA
Diabetes and obesity as complex metabolic disorders, and pregnancy outcomes | |
| | | | |
| | | | Mohseni Meybodi A
Detection of different kind of human papillomavirus in normal pregnancy and in pregnant women with insulin dependent diabetes mellitus |
| | | | |
| | | | Riviello C
Breastfeeding and Basal Insulin Requirement in Type 1 Diabetic Women | |
| | | | |
| | | | Takao Y
Human luteal cells express Monoamine oxidase-A during early pregnancy |
| | | | |
| | | | Tica Oana Sorina
Abnormal pregnancies after clomiphene citrate |
| | | | |
| |
11:10 - 13:10
ORAL PRESENTATIONS - PATOPHYSIOLOGY OF PCOS | | | | | Benelli E
Aldosterone and renin plasma levels in young patients with Polycystic Ovary Syndrome | |
| | | | |
| | | | Campagna G
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evalutation of metabolic impact |
| | | | |
| | | | Davydova GN
Clinical features of polycystic ovary syndrome | |
| | | | |
| | | | Domingues T
Polycystic ovarian disease does not enhance rescue of corpus luteum by administration of recombinant (r)hCG on the first day of the menses | |
| | | | |
| | | | Falbo A
Effects of metformin with or without folate supplementation on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome | |
| | | | |
| | | | Georgopoulos NA
The relationship of Antimüllerian hormone (AMH) to LH and FSH serum levels and the impact of obesity, in young women with polycystic ovary syndrome (PCOS) | |
| | | | |
| | | | Lanzoni C
Metformin administration restores allopregnanolone response to ACTH stimulation in overweight hyperinsulinemic PCOS patients | |
| | | | |
| | | | Matteo M
Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile PCOS women | |
| | | | |
| | | | Rinaldi E
Glucose metabolism and adrenal activity | |
| | | | |
| | | | Shebl O
Effect of ovarian drilling on serum AMH level in women with PCOS |
| | | | |
| | | | Daga A
AMH as a marker of ovarian activity in multifollicular ovaries | |
| | | | |
| | | | Tuck A
Increased kit ligand levels in human polycystic ovaries | |
| | | | |
| |
15:00 - 17:00
ORAL PRESENTATIONS - ADVANCES IN CONTRACEPTION | | | | | Ågren U
Impact of a Unique, Monophasic Combined Oral Contraceptive Containing Nomegestrol Acetate/17 Beta-Estradiol on SHBG and Androgenic Markers in Two Open-Label, Randomized, Comparative Studies | |
| | | | |
| | | | Brache V
Immediate preovulatory administration of 30mg ulipristal acetate significantly delays subsequent follicular rupture | |
| | | | |
| | | | Duijkers IJM
Effects of a Unique, Monophasic Combined Oral Contraceptive Containing Nomegestrol Acetate/17 Beta-Estradiol on Ovarian Function | |
| | | | |
| | | | Gaussem P
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17ßestradiol, compared with those of levonorgestrel/ethinyl estradiol | |
| | | | |
| | | | Heliövaara-Peippo S
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on quality of life among women with menorrhagia: a 10-year randomised controlled trial | |
| | | | |
| | | | Pal D
Acaciaside-B-enriched fraction of Acacia auriculiformis possesses spermicidal as well as anti-HIV activity with wide margin of safety | |
| | | | |
| | | | Saha P
Puerarin, a selective estrogen receptor modulator, disrupts embryo-uterine communication and inhibits implantation in rats | |
| | | | |
| | | | Saki G
In vivo study the effect of Oxamate on LDH-C4 activity of sperm in Rat |
| | | | |
| | | | Sbano FM
Effectiveness of LNG-IUD in relation to FSH serum levels in patients with menorrhagia |
| | | | |
| | | | Wildemeersch D
Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding |
| | | | |
| |
17:20 - 19:20
ORAL PRESENTATIONS - CLINICAL AND THERAPEUTICAL ASPECTS OF PCOS | | | | | Capalbo A
The missense Ser312Asn variant of LHCGR gene is strongly associated with PCOS: a case-control |
| | | | |
| | | | Glinski L
Insulin regulates both basal and stimulated gonadotropins secretion in PCOS patients: different effect of metformin, hypocaloric and low glucidic diet | |
| | | | |
| | | | Huang W
Association between serum adipocyte factor and insulin resistance in PCOS | |
| | | | |
| | | | Londero AP
Policystic ovary syndrome and benign breast disease: two aspects of the same dysmetabolic condition | |
| | | | |
| | | | Perini D
Comparison of effects of 3 mg drospirenone plus 20 mg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with PCOS |
| | | | |
| | | | Ricciardi L
Follicular function and metabolic assessment in obese women with polycystic ovary syndrome: Antimullerian hormone after insulin-sensitizing therapy | |
| | | | |
| | | | Rice S
Metformin inhibits aromatase via an ERK-mediated pathway | |
| | | | |
| | | | Rinaldi E
Autoimmunity and Polycystic Ovary Syndrome | |
| | | | |
| | | | Sanna S
Metformin effect in PCOS patients is not dose dependent |
| | | | |
| | | | Signori C
Metabolic features and uterine artery color doppler analysis in polycistic ovary syndrome (PCOS) and control women | |
| | | | |
| | | | Talaee RZ
Genetic predisposition of polycystic ovarian disease: Report of clusters within 10 large families; inclusion of novel signs and describing male PCOD | |
| | | | |
| |
|
| | | | |
| | | | | VERDE | 08:30 - 13:10
LIVE REPRODUCTIVE SURGERY SESSION SPONSORED BY JOHNSON & JOHNSON MEDICAL / LIVE SURGERY SESSION FROM PISA UNIVERSITY HOSPITAL | | | | | Mettler Liselotte
PLENARY LECTURE - Gyne surgery under imaging conditions |
| | | | |
| | | | Angioni Stefano
Hysterectomy, Subtotal hysterectomy, Myomectomy, Single port laparoscopic surgery, Office hysteroscopy |
| | | | |
| |
14:10 - 15:00
DEBATE - IS THERE A ROLE FOR METFORMIN IN THE TREATMENT OF PCOS WOMEN ? | | |
15:00 - 17:00
PLENARY SESSION - ANDROGENS IN WOMEN | | | | | Sultan Charles
Congenital adrenal hyperplasia: from clinic to gene, from gene to clinic | |
| | | | |
| | | | Smetnik Vera
The androgen-deficiency syndrome and related diseases | |
| | | | |
| |
17:20 - 19:20
PLENARY SESSION - FEMALE SEXUALITY | | | | | Nappi Rossella
Brain control of female sexuality: neuroendocrine control | |
| | | | |
| | | | Caruso Salvatore
Age and metabolic related structural changes in female clitoral cavernosal tissue |
| | | | |
| |
|
| | | | |
|
|